ArticlePloS one2018

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

Konstantin Schlick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.